XYLOCAINE 10 mg/ml ADRENALINE 0.005 mg/ml, solution for injection bottle, 20 ml
Active ingredients: Epinephrine, Lidocaine hydrochloride, Lidocaine hydrochloride, Epinephrine bitartrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 20 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYLOCAINE 10 mg/ml ADRENALINE 0,005 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 1 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1950
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68649778CIP73115212CIP133400931152125Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADRÉNALINEsolution | 0,005 mg · 1 ml | FT |
| TARTRATE D'ADRÉNALINEsolution | 0,0091 mg · 1 ml | SA |
| CHLORHYDRATE DE LIDOCAÏNEsolution | 10,66 mg · 1 ml | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 10 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.